Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole K L Helgestad

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Circulation|August 11, 2020
Letter by Helgestad et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support"Ole K L Helgestad, Sören Möller, Jacob E Møller
European Journal of Heart Failure|November 16, 2019
Mechanical respiratory support in cardiogenic shock: replyOle K L Helgestad, Hanne B Ravn, Jakob Josiassen, et al.
Shock (Augusta, Ga.)|July 19, 2021
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Measured at Admission is Associated With Development of Late Cardiogenic Shock and Mortality in Patients With ST-Segment Elevation Myocardial InfarctionMartin Frydland, Rasmus Møgelvang, Jacob Eifer Møller, et al.
European Heart Journal. Acute Cardiovascular Care|June 21, 2021
Data-driven point-of-care risk model in patients with acute myocardial infarction and cardiogenic shockOle K L Helgestad, Amalie L Povlsen, Jakob Josiassen, et al.
European Heart Journal. Acute Cardiovascular Care|November 10, 2022
Soluble ST2 in plasma is associated with post-procedural no-or-slow reflow after primary percutaneous coronary intervention in ST-elevation myocardial infarctionFrederik T Søndergaard, Rasmus P Beske, Martin Frydland, et al.
International Journal of Cardiology|January 5, 2024
Circulating biomarkers of the CS4P and CLIP scores are not altered in a pig model of acute cardiogenic shock and additional short-term circulatory supportChristian Riehle, Jan-Thorben Sieweke, Nanna Louise Junker Udesen, et al.
Journal of Cardiovascular Translational Research|May 12, 2021
Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular FailureJakob Josiassen, Ole K L Helgestad, Nanna L J Udesen, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 30, 2021
Biventricular Compared to Left Ventricular Impella and Norepinephrine Support in a Porcine Model of Severe Cardiogenic ShockNanna L J Udesen, Jakob Josiassen, Ole K L Helgestad, et al.
Journal of the American Heart Association|December 20, 2024
Hemodynamic Characteristics and Prognostic Implication of Modified Society for Cardiovascular Angiography and Interventions Shock Classification in Comatose Patients With Out-of-Hospital Cardiac ArrestLouise Linde, Rasmus P Beske, Martin A S Meyer, et al.
The American Journal of Cardiology|December 31, 2020
Incidence, Predictors, and Outcome of In-Hospital Bleeding in Patients With Cardiogenic Shock Complicating Acute Myocardial InfarctionHanna Ratcovich, Jakob Josiassen, Ole K L Helgestad, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Circulation|August 11, 2020
Letter by Helgestad et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support"Ole K L Helgestad, Sören Möller, Jacob E Møller
European Journal of Heart Failure|November 16, 2019
Mechanical respiratory support in cardiogenic shock: replyOle K L Helgestad, Hanne B Ravn, Jakob Josiassen, et al.
Shock (Augusta, Ga.)|July 19, 2021
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Measured at Admission is Associated With Development of Late Cardiogenic Shock and Mortality in Patients With ST-Segment Elevation Myocardial InfarctionMartin Frydland, Rasmus Møgelvang, Jacob Eifer Møller, et al.
European Heart Journal. Acute Cardiovascular Care|June 21, 2021
Data-driven point-of-care risk model in patients with acute myocardial infarction and cardiogenic shockOle K L Helgestad, Amalie L Povlsen, Jakob Josiassen, et al.
European Heart Journal. Acute Cardiovascular Care|November 10, 2022
Soluble ST2 in plasma is associated with post-procedural no-or-slow reflow after primary percutaneous coronary intervention in ST-elevation myocardial infarctionFrederik T Søndergaard, Rasmus P Beske, Martin Frydland, et al.
International Journal of Cardiology|January 5, 2024
Circulating biomarkers of the CS4P and CLIP scores are not altered in a pig model of acute cardiogenic shock and additional short-term circulatory supportChristian Riehle, Jan-Thorben Sieweke, Nanna Louise Junker Udesen, et al.
Journal of Cardiovascular Translational Research|May 12, 2021
Impella RP Versus Pharmacologic Vasoactive Treatment in Profound Cardiogenic Shock due to Right Ventricular FailureJakob Josiassen, Ole K L Helgestad, Nanna L J Udesen, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 30, 2021
Biventricular Compared to Left Ventricular Impella and Norepinephrine Support in a Porcine Model of Severe Cardiogenic ShockNanna L J Udesen, Jakob Josiassen, Ole K L Helgestad, et al.
Journal of the American Heart Association|December 20, 2024
Hemodynamic Characteristics and Prognostic Implication of Modified Society for Cardiovascular Angiography and Interventions Shock Classification in Comatose Patients With Out-of-Hospital Cardiac ArrestLouise Linde, Rasmus P Beske, Martin A S Meyer, et al.
The American Journal of Cardiology|December 31, 2020
Incidence, Predictors, and Outcome of In-Hospital Bleeding in Patients With Cardiogenic Shock Complicating Acute Myocardial InfarctionHanna Ratcovich, Jakob Josiassen, Ole K L Helgestad, et al.
Pageof 2